AMR surveillance tracks changes in microbial populations, permits the early detection of resistant strains of public health importance, and supports the prompt notification and investigation of outbreaks.

Surveillance findings are needed to inform clinical therapy decisions, to guide policy recommendations, and to assess the impact of resistance containment interventions.

Resources are shared here on global AMR surveillance systems strengthening across human health, animal health and agricultural sectors.

Interphylum dissemination of NDM-5-positive plasmids in hospital wastewater from Fuzhou, China: a single-centre, culture-independent, plasmid transmission study

This study examined the in-situ transfer of the globally dominant New Delhi metallo-β-lactamase (NDM)-5-positive IncX3 plasmid (denoted pX3_NDM-5) in hospital wastewater to simulate a real-world, One Health antimicrobial resistance context. 

Strengthening Partnerships to Facilitate Collaborative Nurse-Led Research Projects on Antimicrobial Resistance in Brazi

This article featured on page 50 of the Global Network WHO Collaborating Center Magazine advocates for the establishment and enhancement of partnerships to facilitate collaborative nurse-led research projects aimed at addressing the challenge of antimicrobial resistance (AMR) in Brazil.  

MAAP Country Report

The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project provide insight into the AMR burden and antimicrobial consumption (AMC) collectively across 14 African countries. This reports provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa. 

AMR Register

This is a Vivli initiative dedicated to helping industry share antimicrobial resistance surveillance data with researchers in the fight against AMR

Measuring Infectious Causes and Resistance Outcomes for Burden Estimation (MICROBE)

This interactive visualization tool helps you to explore estimates for the burden of infections classified by the involved organ system, causative microorganism, and resistance to treatment.

An ISO-certified genomics workflow for identification and surveillance of antimicrobial resistance

This study describes the development and validation of abritAMR, an ISO-certified bioinformatics platform for genomics-based bacterial AMR gene detection spread.

Sustaining Action Against Antimicrobial Resistance: A Case Series of Country Experiences

This report pinpoints many human-led behaviors that have led to the increased occurrence of AMR in different settings and what measures can be taken to curb the spread.

Training on GLASS methodology for national surveillance of antimicrobial consumption

This course is designed for multidisciplinary professionals in charge of implementing AMC surveillance at national and local level, drug utilization researchers, members of AMR committees, and everyone interested in building competencies in key AMC surveillance functions.

Antimicrobials supplied in community pharmacies

This study was undertaken to determine the patterns of community supply of antiviral and antibacterial agents from community pharmacies during the COVID-19 pandemic in selected countries in eastern Europe and central Asia.

Antimicrobial resistance surveillance in Europe 2022
This report explores AMR in the WHO European Region, and suggests that AMR varies widely depending on the bacterial species, antimicrobial group, and geographical region. It is the first in a series published jointly by the European Centre for Disease Prevention and Control (‎ECDC)‎ and the WHO Regional Office for Europe that includes AMR data from invasive isolates in Europe. Download full report here.

AMR Surveillance: Past, Present, and the Future
A broad-based discussion with a holistic overview on the past, the present, and the future of antimicrobial resistance (AMR). It looks at surveillance objectives, surveillance models, role of governmental authorities in AMR Surveillance in human health, and priority action areas for the future. PDF,VIDEO.

WHO: Global Antimicrobial Resistance Surveillance System (GLASS)
The Global Antimicrobial Resistance Surveillance System (GLASS) has been developed to facilitate and encourage a standardized approach to AMR surveillance globally and in turn support the implementation of the Global action plan on antimicrobial resistance.

The Global Antimicrobial Resistance Surveillance System Manual for Early Implementation addresses the early phase of implementation of GLASS, focussing on surveillance of resistance in common human bacterial pathogens. The intended readership of this publication is public health professionals and health authorities responsible for national AMR surveillance. It outlines the GLASS standards and describes the road map for implementation of the system between 2015 and 2019. Further development of GLASS will be based on the lessons learnt during this period. The GLASS report 2020, which includes data from 66 countries, is available here

WHO: Surveillance standards for antimicrobial resistance
The purpose of this manual is to provide national agencies with a framework within which existing surveillance of communicable disease and infection can be reviewed in order to determine the priorities for epidemiological surveillance of diseases caused by microorganisms exhibiting antimicrobial resistance. The manner of implementation of antimicrobial resistance surveillance most appropriate in a particular country will be determined by a number of factors, including the range of diseases of public health significance, the organization of healthcare services and the resources available.

BD Tool: Calculate the estimated clinical and economic impact of antimicrobial resistance
Infections caused by resistant organisms are associated with high mortality rates and costs compared to those susceptible to antimicrobial therapy. Delays in appropriate diagnosis and treatment increase the chances of a negative clinical outcome for patients with these infections. This calculator quantifies the estimated clinical and economic impact of antimicrobial resistance.

SEDRIC: Harnessing alternative sources of antimicrobial resistance data to support surveillance in low-resource settings
The Surveillance and Epidemiology of Drug-resistant Infections Consortium (SEDRIC) is a think tank designed to bring together a range of international experts to share expertise and take action to tackle the gaps in drug-resistant infection surveillance and epidemiology. This paper explores how untapped sources of data could provide a short-term solution that bridges the gap between now and the time when routine surveillance capacity will have been established and how this could continue to support surveillance efforts in the future. SEDRIC also maps global AMR surveillance projects

If you are working in AMR surveillance you can join their global network of experts

ATLAS, Antimicrobial Testing Leadership and Surveillance
ATLAS includes a fully-searchable database of surveillance data. Users may process data from one or more surveillance programmes to produce reports, tables and geographic heatmaps of antibacterial or antifungal resistance over time.

Africa CDC: Anti-Microbial Resistance Surveillance Network AMRSNET
In Africa, AMR has already been documented to be a problem for HIV and the pathogens that cause malaria, tuberculosis, typhoid, cholera, meningitis, gonorrhea, and dysentery. Recognizing the urgent need for action, the World Health Assembly adopted the Global Action Plan on Antimicrobial Resistance in May 2015. In accordance with the Global Action Plan and to meet needs specific to Africa, Africa CDC have established the Anti-Microbial Resistance Surveillance Network (AMRSNET). AMRSNET is a network of public health institutions and leaders from human and animal health sectors who will collaborate to measure, prevent, and mitigate harms from AMR organisms.

University of Oxford TropMed webinars: AMR Surveillance
In these webinars from the University of Oxford Centre for Tropical Medicine and Global Health TropMed series, clinical microbiologists from the Centre's oversees units discussed antimicrobial resistance surveillance. Prof Paul Turner (COMRU) discusses the pressing need for quality laboratory data in low and middle-income countries, for better antimicrobial resistance surveillance. Prof H Rogier van Doorn (OUCRU) discusses AMR surveillance data, from antibiotic susceptibility testing results to treatment regimen. 

GLASS guide for national surveillance systems for monitoring antimicrobial consumption in hospitals
This is a guide for national surveillance systems for monitoring antimicrobial consumption in hospitals. It aims to help countries establish mechanisms enabling routine monitoring of antimicrobial consumption, particularly in low-resource settings, that can generate data to help build a greater understanding of how antimicrobials are being used and consumed in national, regional, and local hospitals.

Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP): general protocol
This is a general protocol document for the development and pilot testing of the Enhanced Gonorrhoea Surveillance Programme (EGASP). It describes the objectives and the methods of EGASP surveillance and guidance on how to implement and monitor EGASP.

Antimicrobial resistance surveillance in Europe 2022 – 2020 data (2022)
This is a jointly published report by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe on Antimicrobial resistance surveillance in Europe. The report pinpoints the widespread of AMR in the region and what the ECDC and WHO are doing to curtail it.